September 30, 2020

Volume X, Number 274

September 29, 2020

Subscribe to Latest Legal News and Analysis

September 28, 2020

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

Date Title Organization
14
Apr
European Court to Clarify Responsibilities and Liability for Medical Devices Covington & Burling LLP
14
Apr
U.S. Department of Transportation Publishes Rule Permitting Use of Electronic Drug Testing Custody and Control Form Jackson Lewis P.C.
13
Apr
Supreme Court Rules That Providers and Suppliers Cannot Challenge Medicaid Reimbursement Rates in Federal Court Epstein Becker & Green, P.C.
13
Apr
Chicago’s Technology Community Includes a Growing Automotive Technology and Research Sector Foley & Lardner LLP
10
Apr
Farmers Markets, Roadside Stands, and CSA Programs Evade the Long Arm of the Law Morgan, Lewis & Bockius LLP
9
Apr
CMS Takes Initial Steps to Address Medicare & Medicaid Coverage for Biosimilars Mintz
9
Apr
Apotex Has Standing Despite Benicar Patent Disclaimer Foley & Lardner LLP
9
Apr
Food Labeling, Food Safety and Nutrition Update Mintz
9
Apr
Massachusetts Announces Significant Changes to the Medical Marijuana Dispensary Program Mintz
8
Apr
European Union Policy Update—April re: Digital Single Market Policy, Finance, Life Sciences and More Covington & Burling LLP
8
Apr
The Newborn Screening Saves Lives Reauthorization Act: Implications for Human Subjects Research McDermott Will & Emery
7
Apr
CMS Releases New Reimbursement Guidance for Biosimilars Covington & Burling LLP
7
Apr
False Advertising Claim Washed Away for Lack of Standing Proskauer Rose LLP
7
Apr
Waiting On Sequenom: Pharma Patents Foley & Lardner LLP
6
Apr
Pay for Delay – Big Pharma’s Dirty Secret Mahany Law
3
Apr
CMS Offers a New Accountable Care Organization Model Greenberg Traurig, LLP
2
Apr
Moving to the Cloud: Some Key Considerations for Healthcare Entities Covington & Burling LLP
2
Apr
Roxane Labs and Par Pharm v. Jazz Pharm: Denying Institution CBM2014-00161, 175 Faegre Drinker
31
Mar
German Exemptions from Mandatory Rebates for Pharma Companies Are in Line with EU State Aid Rules Covington & Burling LLP
31
Mar
No Collateral Challenge Of Patent Application Revival Foley & Lardner LLP

Pages

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS

Upcoming Legal Education Events

Thursday, October 1, 2020
Wednesday, October 14, 2020
Wednesday, October 14, 2020
Tuesday, October 27, 2020 to Wednesday, October 28, 2020